CNI-1493 for Treatment of Moderate to Severe Crohn's Disease
Public ClinicalTrials.gov record NCT00038766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-controlled Study of CNI-1493 for Treatment of Moderate to Severe Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether CNI-1493 is safe and effective in the treatment of moderate to severe Crohn's Disease.
Study identification
- NCT ID
- NCT00038766
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 33 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2002
- Primary completion
- May 31, 2003
- Completion
- May 31, 2003
- Last update posted
- Aug 22, 2012
2002 – 2003
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Institute of Healthcare Assessment | San Diego | California | 92120 | — |
| University of Florida | Gainesville | Florida | — | — |
| Atlanta Gastroenterology Associates | Atlanta | Georgia | 30342 | — |
| Northwestern University | Chicago | Illinois | — | — |
| University of Chicago | Chicago | Illinois | — | — |
| Washington University School of Medicine | St Louis | Missouri | — | — |
| Long Island Clinical Research Associates | Great Neck | New York | 11021 | — |
| Mount Sinai School of Medicine | New York | New York | — | — |
| Charlotte Gastroenterology and Hepatology, PLLC | Charlotte | North Carolina | 28207 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Oklahoma Foundation for Digestive Research | Oklahoma City | Oklahoma | — | — |
| Regional Gastroenterology Associates of Lancaster, Ltd. | Lancaster | Pennsylvania | 17604 | — |
| Digestive and Liver Disease Specialists | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00038766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 22, 2012 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00038766 live on ClinicalTrials.gov.